Physician profile
David R Lawrence
NPI 1164597910
$31,185.29
in general payments reported to CMS, 2019-2025
8 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $2,159 · 2021: $3,104 · 2022: $13K · 2023: $2,674 · 2024: $44.73 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,949 · Food and Beverage: $950 · Travel and Lodging: $33.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,949.04 |
| Food and Beverage | $949.84 |
| Travel and Lodging | $33.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $14,856.80 | 2019-2022 | |
| Medical Device Business Services, INC. | $10,055.99 | 2021-2023 | Conduit, Teligen |
| Medtronic, INC. | $2,936.83 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Unid_pass, Catalyft Pl Expandable Interbody System |
| Medtronic USA, INC. | $2,322.00 | 2019-2020 | |
| Camber Spine Technologies LLC | $471.64 | 2023 | |
| Alphatec Spine, INC | $223.19 | 2019 | |
| Nuvasive, INC. | $184.57 | 2019 | |
| Biocomposites INC | $134.27 | 2023 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.